OLRATAN TRIO 12.5 (Olmesartan Medoxomil (20mg) + Cilnidipine (10mg) + Chlorthalidone (12.5mg))

OLRATAN-TRIO 12.5 Tablet is a formulation that combines several medications aimed at managing high blood pressure, particularly in cases where monotherapy has proven ineffective. The primary purpose of this medication is to help decrease elevated blood pressure levels, thereby lowering the risk of serious cardiovascular events such as heart attacks and strokes. It is advisable to take the OLRATAN-TRIO 12.5 Tablet consistently, either with or without food, at a set time each day to maintain stable blood levels of the medication. The appropriate dosage will be determined by your healthcare provider based on your specific medical condition and response to treatment. Due to the presence of a diuretic agent in this medication, which increases urine production, it is recommended that individuals avoid taking it close to bedtime to minimize nocturnal urination. Regular use is essential for optimal therapeutic effects, even in the absence of noticeable symptoms, as high blood pressure often does not present with obvious signs. Discontinuing this medication could increase the likelihood of severe health issues. Patients are encouraged to stay well-hydrated while on this medication to alleviate symptoms such as muscle weakness, dry mouth, and intense thirst. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is advised to ensure effective treatment.